Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX

被引:0
|
作者
McCarthy, Michael [1 ]
Jimenez, Rafael [1 ]
Hernandez, Loren Herrera [1 ]
Lohse, Christine [1 ]
Thompson, R. Houston [1 ]
Boorjian, Stephen [1 ]
Leibovich, Bradley [1 ]
Cheville, John [1 ]
Gupta, Sounak [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
590
引用
收藏
页码:634 / 634
页数:1
相关论文
共 50 条
  • [1] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX
    McCarthy, Michael R.
    Nichols, Paige E.
    Sharma, Vidit
    Stanton, Melissa L.
    Reynolds, Jordan P.
    Pitel, Beth A.
    Halling, Kevin C.
    Lohse, Christine M.
    Herrera-Hernandez, Loren
    Thompson, Houston
    Leibovich, Bradley C.
    Jimenez, Rafael E.
    Boorjian, Stephen A.
    Cheville, John C.
    Gupta, Sounak
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (07) : 817 - 825
  • [2] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX
    McCarthy, Michael
    Jimenez, Rafael
    Hernandez, Loren Herrera
    Lohse, Christine
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Cheville, John
    Gupta, Sounak
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 634 - 634
  • [3] Genetic Alterations of Both MEN1/ATRX and TP53/RB1 in Pancreatic Neuroendocrine Neoplasms
    Zhang, Ming-Yi
    He, Du
    Zhang, Shuang
    Liu, Ji-Yan
    PANCREAS, 2022, 51 (06) : e91 - e93
  • [4] Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer
    Humid, Anis A.
    Gray, Kathryn P.
    Shaw, Grace
    MacConaill, Laura E.
    Evan, Carolyn
    Bernard, Brandon
    Loda, Massimo
    Corcoran, Niall M.
    Van Allen, Eliezer M.
    Choudhury, Atish D.
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2019, 76 (01) : 89 - 97
  • [5] Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas
    Pellin, A
    Boix-Ferrero, J
    Carpio, D
    Lopez-Terrada, D
    Carda, C
    Navarro, S
    Peydro-Olaya, A
    Triche, TJ
    Llombart-Bosch, A
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1997, 6 (06) : 333 - 341
  • [6] TP53 and RB1 alterations promote reprogramming and antiandrogen resistance in advanced prostate cancer
    Mu, Ping
    Cao, Zhen
    Hoover, Elizabeth
    Wongvipat, John
    Huang, Chun-Hao
    Karthaus, Wouter
    Abida, Wassim
    De Stanchina, Elise
    Sawyers, Charles
    CANCER RESEARCH, 2015, 75
  • [7] Concurrent RB1/TP53 Alterations in Targetable EGFRMutant Lung Adenocarcinoma Imply Aggressive Treatment
    Li, Y.
    Zhang, Y.
    Zhang, R.
    Nie, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S630 - S630
  • [8] Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas
    Watanabe, T
    Yokoo, H
    Yokoo, M
    Yonekawa, Y
    Kleihues, P
    Ohgaki, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (12): : 1181 - 1189
  • [9] RB1 and TP53 pathways in radiation-induced sarcomas
    N Gonin-Laurent
    N S Hadj-Hamou
    N Vogt
    C Houdayer
    M Gauthiers-Villars
    C Dehainault
    X Sastre-Garau
    S Chevillard
    B Malfoy
    Oncogene, 2007, 26 : 6106 - 6112
  • [10] RB1 and TP53 pathways in radiation-induced sarcomas
    Gonin-Laurent, N.
    Hadj-Hamou, N. S.
    Vogt, N.
    Houdayer, C.
    Gauthiers-Villars, M.
    Dehainault, C.
    Sastre-Garau, X.
    Chevillard, S.
    Malfoy, B.
    ONCOGENE, 2007, 26 (41) : 6106 - 6112